Related Experiment Video

Updated: Oct 4, 2025

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

604

Editorial: Immune Cell Lineage Reprogramming in Cancer

Jianmei W Leavenworth1,2,3, Lewis Zhichang Shi2,3,4, Xi Wang5,6,7,8

  • 1Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL, United States.

Frontiers in Immunology
|February 7, 2022
PubMed
Summary

No abstract available in PubMed .

Keywords:
cancer immunotherapyepigenetic regulationhelper T-cellslineage reprogrammingnatural killer cellsregulatory T-cellstumor immunitytumor-associated macrophages

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

953
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

6.2K

Related Concept Videos